Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 1,976–2,000 of 27,380 studies, newest first · page 80 of 1096.

January 2026 25

  1. 2026-01-01

    Associations of modifiable and non-modifiable risk factors with longitudinal white matter hyperintensities, amyloid-β and tau - a prospective cohort study

    ✓ Peer-reviewed Vascular contributions The Journal of Prevention of Alzheimer s Disease

    Key finding: Non-modifiable (age, apolipoprotein E (APOE) ɛ4 genotype and sex) and modifiable risk factors (co-morbidities at baseline, such as hypertension and cardiovascular disease, BMI, and sleep duration) were analyzed with mixed-effects models, adjusted for age and sex, to predict longitudinal measurements of WMH, Aβ and tau. +4 more findings

  2. 2026-01-01

    Silent yet impaired: Hidden memory processing deficits in asymptomatic individuals with moderate‐to‐severe white matter hyperintensities

    ✓ Peer-reviewed Vascular contributions Alzheimer s & Dementia

    Key finding: Individuals with msWMH showed systematic deficits in face-memory processing across encoding, maintenance, and retrieval, accompanied by reduced theta power and synchronization, altered alpha power, and disrupted theta-gamma coupling. +4 more findings

  3. 2026-01-01
  4. 2026-01-01

    The association of estimated glucose disposal rate with white matter hyperintensities: A large prospective cohort study

    ✓ Peer-reviewed Vascular contributions The Journal of Prevention of Alzheimer s Disease

    Key finding: Each 1-SD increase in eGDR was significantly associated with a reduction in WMH volume (β = -0.057; 95% CI: -0.062 to -0.051; p 0.05). +2 more findings

  5. 2026-01-01

    Elevated serum inflammasome adaptor protein ASC is associated with white matter hyperintensities in vascular cognitive impairment

    ✓ Peer-reviewed Vascular contributions Brain Communications

    Key finding: Compared to controls, serum ASC levels were increased in the VCI clinical subgroups, namely, cognitive impaired, no dementia with CeVD, AD with CeVD and VaD. +3 more findings

  6. 2026-01-01

    The Inaugural Voyage of the South Asian Journal of Geriatric Medicine, Surgery, Palliative Care, and Hospice

    ✓ Peer-reviewed End-of-life care South Asian Journal of Geriatric Medicine Surgery Palliative Care & Hospice

    Key finding: This Journal is not only a new publication but also the culmination of a shared vision and a timely response to one of the most significant demographic shifts in human history: the rapid aging of the South Asian population. +4 more findings

  7. 2026-01-01
  8. 2026-01-01
  9. 2026-01-01

    Physical and psychosocial benefits of an interdisciplinary end-of-life care model for older adults in residential care homes in Hong Kong

    ✓ Peer-reviewed End-of-life care International Psychogeriatrics

    Key finding: Pre-post evaluations revealed significant reductions in physical symptoms, psychosocial-spiritual distresses and information insufficiency of patients in the first three months of service. +3 more findings

  10. 2026-01-01
  11. 2026-01-01

    Advance care planning in Japan: Gaps between policy, ethical understanding, and its translation into clinical practice

    ✓ Peer-reviewed End-of-life care Palliative Care and Social Practice

    Key finding: Misconceptions were common: 38% of participants equated ACP exclusively with decisions to forgo active treatment, and many conflated ACP with current rather than future-oriented care planning. +4 more findings

  12. 2026-01-01

    Behavioral Variant Frontotemporal Dementia With C9orf72 Intermediate Repeat Expansion

    ✓ Peer-reviewed Clinical safety Alzheimer Disease & Associated Disorders

    Key finding: Here, we report a rare case of behavioral variant frontotemporal dementia (bvFTD) associated with a C9orf72 repeat expansion of 49 units, a size that falls within the intermediate-length range. +1 more finding

  13. 2026-01-01

    Assessment of heart rate variability and occurrence of falls in Alzheimer's disease: an exploratory study

    ✓ Peer-reviewed Clinical safety Arquivos de Neuro-Psiquiatria

    Key finding: The AD group presented more falls, whose incidence was associated with HRV components.

  14. 2026-01-01

    Depression and risk of cognitive decline and dementia: Implications and strategies for prevention

    ✓ Peer-reviewed Prevention trials Journal of Geriatric Mental Health

    Key finding: Dementia, a syndrome characterized by a decline in cognitive function beyond what is expected from normal aging, poses a significant global health challenge. +4 more findings

  15. 2026-01-01

    Updates on Mediterranean diet and health status: active ingredients and pharmacological mechanisms

    ✓ Peer-reviewed Prevention trials Chalmers Research (Chalmers University of Technology)

    Key finding: The Mediterranean diet (MedDiet) is among the most extensively studied dietary patterns and has been consistently associated with reduced risk of all-cause mortality, cardiovascular disease, metabolic disorders, cognitive decline and several types of cancers. +1 more finding

  16. 2026-01-01

    Impact of cognitive training on claims‐based diagnosed dementia over 20 years: evidence from the ACTIVE study

    ✓ Peer-reviewed Prevention trials Alzheimer s & Dementia Translational Research & Clinical Interventions

    Key finding: Cognitive training involving speed of cognitive processing has the potential to delay the diagnosis of ADRD.

  17. 2026-01-01

    Microglia-Derived Extracellular Vesicles from Alzheimer’s Disease Patients Carry miRNAs Driving a Neuroinflammatory Response

    ✓ Peer-reviewed Inflammation and the immune system Molecular Neurobiology

    Key finding: Using a HEK TLR reporter cell system, we found that these miRNA are potent activators of human TLR8, an established RNA sensor. +1 more finding

  18. 2026-01-01

    Neuroinflammation demonstrated by 11 C‐ER176 PET with amyloid and tau pathology

    ✓ Peer-reviewed Inflammation and the immune system Alzheimer s & Dementia

    Key finding: These findings suggest probable amyloid association with early microglial activation, while tau pathology is closely tied to wider distribution of neuroinflammation. +2 more findings

  19. 2026-01-01

    Inhibiting Glycogen Synthase Kinase 3 Suppresses TDP-43-Mediated Neurotoxicity in a Caspase-Dependent Manner

    ✓ Peer-reviewed Brain tissue and pathology Molecular Neurobiology

    Key finding: We show that TDP-43 activates GSK3 and promotes caspase-dependent cleavage of TDP-43, generating C-terminal fragments. +1 more finding

  20. 2026-01-01

    Small molecule JRMS modulating importin-β1 chaperone activity as a therapeutic strategy reducing TDP-43 pathology

    ✓ Peer-reviewed Brain tissue and pathology Neurotherapeutics

    Key finding: Previous studies have demonstrated that increased expression of KPNB1 solubilizes TDP-43 aggregates and restores its nuclear localization. +1 more finding

  21. 2026-01-01

    Prediabetes as a critical stage for risk of dementia and stroke: evidence from the UK Biobank and Mendelian randomization.:evidence from the UK Biobank and Mendelian Randomization

    ✓ Peer-reviewed Long-term cohort studies Pure Amsterdam UMC

    Key finding: During a median 13.7 years of follow-up, prediabetes (n=52,693) was associated with higher risks of vascular dementia (hazard ratio (HR):1.36; 95% confidence interval (CI): 1.14-1.61), stroke (HR:1.09; 95% CI: 1.01-1.16), ischemic stroke (HR:1.10; 95% CI: 1.02-1.19), and intracerebral hemorrhage (HR:1.19; 95% CI: 1.01-1.39) compared with normoglycemia, after adjustment for major confounding factors and across extensive sensitivity analyses. +4 more findings

  22. 2026-01-01

    Delirium and adverse clinical outcomes: a matched cohort study in the UK Biobank

    ✓ Peer-reviewed Long-term cohort studies The Lancet Healthy Longevity

    Key finding: Over a maximum follow-up of 26 years, the median time to event was 1·2 years (IQR 0·2-3·3) in the delirium group and 1·3 years (0·3-3·6) in the control group. +4 more findings

  23. 2026-01-01

    Peripheral biomarkers associated with apathy and predicting response to methylphenidate: Secondary analysis of the Apathy in Dementia Methylphenidate Trial 2 (ADMET2) study

    ✓ Peer-reviewed Cognitive tests and assessment International Psychogeriatrics

    Key finding: In the ADMET2 biomarker subset (n = 44, MPH:21, age:75 years, MMSE:20.2), higher baseline TNF was associated with higher M6 NPI-A [B(SE)= 6.86 (1.71), p = .0003], and multivariable models found lower baseline TNF [B(SE)= 8.28(1.61), p < .001] and higher baseline S100B [B(SE)= -6.41(1.95), p = .002] were associated with lower M6 NPI-A. +4 more findings

  24. 2026-01-01

    Comparative methods for determining MoCA, MMSE, and CDR cut‐offs in Alzheimer's disease: insights from the ADNI study

    ✓ Peer-reviewed Cognitive tests and assessment Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring

    Key finding: For MCI, MoCA cut-offs were 24 (three methods) and 25 (Youden's J Index). +3 more findings

  25. 2026-01-01

    Identification and functional verification of new molecular targets of blood – cerebrospinal fluid and exosomes from patients with neurodegenerative diseases

    ✓ Peer-reviewed Tau biomarkers Aristotle University of Thessaloniki

    Key finding: Η νευρωνική εκφύλιση και δυσλειτουργία αποτελούν χαρακτηριστικά γνωρίσματα των νευροεκφυλιστικών ασθενειών. Σημαντική πρόκληση είναι η ανάπτυξη αξιόπιστων διαγνωστικών εργαλείων που θα επιτρέπουν την έγκαιρη διάγνωση των νόσων αυτών. Πρώτος στόχος της παρούσας διδακτορικής διατριβής είναι ο ποσοτικό +1 more finding

Browse the library by subject, with the full score breakdown →